Walleye Trading’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Walleye Trading’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-74,662	Closed	-$299K	–	4899
2019 Q4	$299K	Buy	74,662 +42,436	+132%	+$199K	﹤0.01%	2821
2019 Q3	$158K	Sell	32,226 -1,005	-3%	-$5.62K	﹤0.01%	3077
2019 Q2	$202K	Buy	33,231 +22,363	+206%	+$119K	﹤0.01%	2934
2019 Q1	$63K	Buy	10,868 +1,253	+13%	+$12.9K	﹤0.01%	3648
2018 Q4	$129K	Buy	9,615 +5,529	+135%	+$93.2K	﹤0.01%	3741
2018 Q3	$79K	Sell	4,086 -23,570	-85%	-$502K	﹤0.01%	4333
2018 Q2	$707K	Buy	27,656 +25,256	+1,052%	+$589K	﹤0.01%	2480
2018 Q1	$48K	Buy	+2,400	New	+$56K	﹤0.01%	4149

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Trading's DPLO Position: Q1 2020 in Review

Walleye Trading sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 74,662 shares — an estimated $299K sold.

Walleye Trading first reported a position in DPLO in Q1 2018 and held it in 8 quarters. The position peaked at $707K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Walleye Trading reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Walleye Trading sold 74,662 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $299K.
Walleye Trading first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 8 quarters.
Walleye Trading's DIPLOMAT PHARMACY, INC. position peaked at $707K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.